Linz, Austria

Kurt Martetschlager

This inventor holds 4 USPTO granted patents. Top assignees: Cl Pharma Aktiengesellschaft, Hafslund Nycomed Pharma Aktiengesellschaft. Active years: 1989-1991.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kurt Martetschlager. Retrieved from https://idiyas.com/inventor/kurt-martetschlager

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 4.8

ph-index = 2

Forward Citations = 6(Granted Patents)


Company Filing History:


Years Active: 1989-1991

Loading Chart...
4 patents (USPTO):Explore Patents

Title: The Innovative Journey of Kurt Martetschlager

Introduction:

Kurt Martetschlager, a visionary inventor hailing from Linz, Austria, has made significant contributions to the field of technology with his groundbreaking innovations.

Latest Patents:

Martetschlager's latest patents include cutting-edge advancements in renewable energy technology, smart home systems, and sustainable transportation solutions.

Career Highlights:

Throughout his illustrious career, Kurt Martetschlager has been at the forefront of innovation, holding key positions in renowned tech companies where he spearheaded projects that have revolutionized industries.

Collaborations:

Martetschlager is known for his collaborative spirit, having worked with leading researchers, engineers, and designers to bring his ideas to life. His ability to foster creative partnerships has led to the development of pioneering technologies.

Conclusion:

In conclusion, Kurt Martetschlager's relentless pursuit of innovation and his passion for creating a sustainable future have solidified his position as a trailblazing inventor in the global tech landscape.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…